Early stage pharma stock is healthy opportunity

Liam Pryce Jones of Charles Stanley suggests Primark parent company Associated British Foods could be a sell as raw materials costs rise

Synairgen Spun out of Southampton University Hospital, Synairgen is a respiratory drug discovery company working on the development of a drug to combat lung conditions such as asthma and emphysema. While the drug is not expected to be the cure for these debilitating diseases, it is a significant aid to assisting recovery of patients and the reduction of time in hospital. At the beginning of May, the company announced the key ingredient in the drug, interferon-beta, was effective against H5N1 (bird flu) in in-vitro testing. However, Synairgen does not have the funding to take the drug ...